MedCity News February 26, 2025
From the executive boardrooms of pharma companies to academic research centers, one fact is becoming unmistakably clear: making radiopharmaceuticals is an inherently complex, high-stakes endeavor, and the industry is racing to manage the risks of these perishable therapies before the clock runs out
Somewhere in a laboratory, tucked away in its vessel, a small vial sits. However, this vial is special because it is emitting energy – potentially life-saving energy that is disappearing with every fleeting moment. This is not a scene from a thriller – it is the daily reality of radiopharmaceutical manufacturing, where life-saving cancer therapies are manufactured, tested, delivered, and administered while racing against the clock. From the executive boardrooms of pharma companies to academic research centers,...